Skip to content
Wenlo
Sign in
← Markets
After hours · Ends 8:00 PM ET

LNTH Lantheus Holdings Inc.

NASDAQ
$101.00+$0.39 (+0.39%)

As of 3:59:00 PM ET · 1 h old

Loading chart…

Open
$100.52
Previous close
$100.61
Day range
100.52 – 101.11
52-week range
50.16 – 111.86
Volume
25.3K
Avg volume (3M)
1.1M
Market cap
$6.6B
P/E (TTM)
24.31
EPS (TTM)
$4.13
Beta
0.03
Dividend yield
0.00%
Next earnings
—
Ex-dividend
—
Sector
Healthcare

About Lantheus Holdings Inc.

Lantheus Holdings Inc. is a radiopharmaceutical-focused healthcare company that develops, manufactures, and commercializes diagnostic and therapeutic products used to help clinicians detect, localize, and monitor disease. Its portfolio centers on precision diagnostics and nuclear medicine solutions for oncology, cardiology, and neurology, with products designed to support imaging-based diagnosis and patient management across hospitals, clinics, and other healthcare settings. The company’s current business also includes radiotherapeutics and strategic partnerships that complement its core imaging franchise. Lantheus Holdings Inc. serves a global medical market where advanced diagnostic agents play an important role in guiding treatment decisions and improving disease visibility in clinical practice. Headquartered in Bedford, Massachusetts, Lantheus Holdings Inc. operates as a specialized provider in molecular imaging and related healthcare technologies.

LNTH news and filings

Loading filings…

Filings from SEC EDGAR.